Baxter sells plant in Poland to local Nepentes
This article was originally published in Scrip
Nepentes, the Warsaw-based manufacturer and distributor of OTC drugs and medical cosmetics, has bought an infusion solutions plant in Chociw near Lodz, central Poland, fromBaxter’s local division for an undisclosed sum. The company will finance the deal from funds raised through an initial public offering it carried out last December.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.